Jérôme Razanamahery
- Infectious Diseases top 5%
- Oncology top 10%
- Genetics
- Immunology
- Hematology
- Co-authors
- Marie Christiane VekemansJohn C. RichesStephen BoothLisa K. HicksLydia ScarfòFernando Martín‐MoroWilliam A. WoodIoannis Mantzaris
- Topics
- Histiocytic Disorders and Treatments (10 papers)Eosinophilic Disorders and Syndromes (5 papers)Parvovirus B19 Infection Studies (4 papers)
- Cited by
- Infectious DiseasesOncologyGenetics
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Jérôme Razanamahery
17 papers receiving 408 citations
Hit Papers
Peers
Comparison fields: 5 of 46
- Infectious Diseases 255
- Oncology 247
- Genetics 42
- Immunology 42
- Hematology 40
Countries citing papers authored by Jérôme Razanamahery
This map shows the geographic impact of Jérôme Razanamahery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Razanamahery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Razanamahery more than expected).
Fields of papers citing papers by Jérôme Razanamahery
This network shows the impact of papers produced by Jérôme Razanamahery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Razanamahery. The network helps show where Jérôme Razanamahery may publish in the future.
Co-authorship network of co-authors of Jérôme Razanamahery
This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme Razanamahery. A scholar is included among the top collaborators of Jérôme Razanamahery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme Razanamahery. Jérôme Razanamahery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 2 | |
| 8 | 1 | |
| 9 | 45 | |
| 10 | Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patientsbreakdown → | 330 |
| 11 | Multiple arterial thrombosis and pericarditis revealing histiocytosis successfully treated with MEK-inhibitor cobimetinib. | 2 |
| 12 | Tropheryma Whipplei infection mimicking giant cell arteritis flare in a patient treated with interleukin-6 receptor blocker tocilizumab. | 4 |
| 13 | 0 | |
| 14 | 1 | |
| 15 | 9 | |
| 16 | 3 | |
| 17 | 0 | |
| 18 | 1 | |
| 19 | 2 | |
| 20 | 1 |
About Jérôme Razanamahery
Jérôme Razanamahery is a scholar working on Rheumatology, Physiology and Genetics, having authored 21 papers that have together received 412 indexed citations. Recurring topics across this work include Histiocytic Disorders and Treatments (10 papers), Eosinophilic Disorders and Syndromes (5 papers) and Parvovirus B19 Infection Studies (4 papers). The work is most often cited by research in Infectious Diseases (255 citations), Oncology (247 citations) and Genetics (42 citations). Jérôme Razanamahery has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Marie Christiane Vekemans, John C. Riches, Stephen Booth, Lisa K. Hicks, Lydia Scarfò, Fernando Martín‐Moro, William A. Wood, Ioannis Mantzaris, Rushad Patell and Inna Y. Gong. Their work appears in journals such as Journal of Clinical Oncology, Blood and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.